“Ongoing monitoring of incentive programs is critical to determining the effectiveness of financial incentives and their effects on the improvement of cancer screening delivery rates,” researchers wrote.
Beginning next year, the official list price for the cholesterol drug Repatha (evolocumab) will be the lower price Amgen began offering last year to patients on Medicare and those paying for the drug out-of-pocket.
In a recent announcement, Humana and Microsoft launched their new partnership that is focused on creating innovative health care solutions using the latest technology in artificial intelligence and collaboration tools.
A new partnership announced today connects Centene, Walgreens, and RxAdvance, who will be collaborating to build an innovative pharmacy benefit management model in an effort to improve outcomes and lower costs.
According to a report released by California health officials, pharmaceutical companies have significantly raised whole sale prices of their products since the state's drug price transparency law was passed in 2017.
Researchers recently found that unselected genetic testing of all women following breast cancer diagnosis appears highly cost-effective compared with the standard practice of testing select women based on clinical criteria or family history.
Back to Top
Stay in the know. Population Health Learning Network Newsletter